DAWN insider transaction filings
Day One Biopharmaceuticals, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-04-27. Screen DAWN transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-27 | 4 | AI Day1 LLC — 10% owner Access Industries Holdings LLC — 10% owner ACCESS INDUSTRIES MANAGEMENT, LLC — 10% owner Blavatnik Len — 10% owner | Code (U): 12,929,322 @ $21.50 · Disposition to issuer (D): 827,586 (derivative) @ $21.50 | EDGAR |
| 2026-04-23 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Disposition to issuer (D): 204,643 · Disposition to issuer (D): 20,204 · Disposition to issuer (D): 300,000 · Disposition to issuer (D): 147,702 · Disposition to issuer (D): 18,197 · Disposition to issuer (D): 300,000 · +11 more | EDGAR |
| 2026-04-23 | 4 | Merendino Lauren — Chief Commercial Officer | Disposition to issuer (D): 60,157 · Disposition to issuer (D): 330,200 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 18,978 (derivative) · +3 more | EDGAR |
| 2026-04-23 | 4 | Josey John A. — Director | Disposition to issuer (D): 72,292 · Disposition to issuer (D): 63,000 (derivative) · Disposition to issuer (D): 1,181 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 more | EDGAR |
| 2026-04-23 | 4 | Dubow Adam — Gen Counsel & Secretary | Disposition to issuer (D): 72,694 · Disposition to issuer (D): 309,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 105,000 (derivative) · +5 more | EDGAR |
| 2026-04-23 | 4 | VASCONCELLES MICHAEL — Head of Research and Dev. | Disposition to issuer (D): 4,397 · Disposition to issuer (D): 346,000 (derivative) · Disposition to issuer (D): 171,000 (derivative) · Disposition to issuer (D): 226,000 (derivative) · Disposition to issuer (D): 106,875 (derivative) | EDGAR |
| 2026-04-23 | 4 | Grossman William — Director | Disposition to issuer (D): 66,660 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2026-04-23 | 4 | Dable Habib J — Director | Disposition to issuer (D): 66,660 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2026-04-23 | 4 | York Charles N II — COO and CFO | Disposition to issuer (D): 312,025 · Disposition to issuer (D): 497,667 (derivative) · Disposition to issuer (D): 151,000 (derivative) · Disposition to issuer (D): 116,000 (derivative) · Disposition to issuer (D): 162,000 (derivative) · Disposition to issuer (D): 162,000 (derivative) · +5 more | EDGAR |
| 2026-04-23 | 4 | Nicholson Garry A — Director | Disposition to issuer (D): 33,900 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2026-04-23 | 4 | Holles Natalie C. — Director | Disposition to issuer (D): 57,310 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 40,300 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 more | EDGAR |
| 2026-04-23 | 4 | Ramasastry Saira — Director | Disposition to issuer (D): 40,485 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 47,581 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 more | EDGAR |
| 2026-04-23 | 4 | Garland J. Scott — Director | Disposition to issuer (D): 48,072 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) | EDGAR |
| 2026-02-18 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 4,750 · Option exercise (M): 11,688 · Option exercise (M): 11,687 · Option exercise (M): 14,812 · Sale (S): 15,459 @ $11.60 · Option exercise (M): 4,750 (derivative) @ $0 · +3 more | EDGAR |
| 2026-02-18 | 4 | Merendino Lauren — Chief Commercial Officer | Option exercise (M): 3,162 · Option exercise (M): 3,688 · Option exercise (M): 3,687 · Option exercise (M): 4,625 · Sale (S): 5,814 @ $11.60 · Option exercise (M): 3,162 (derivative) @ $0 · +3 more | EDGAR |
| 2026-02-18 | 4 | Dubow Adam — Gen Counsel & Secretary | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,688 · Option exercise (M): 3,687 · Option exercise (M): 4,375 · Sale (S): 6,395 @ $11.60 · +5 more | EDGAR |
| 2026-02-18 | 4 | VASCONCELLES MICHAEL — Head of Research and Dev. | Option exercise (M): 7,125 · Sale (S): 2,728 @ $11.60 · Option exercise (M): 7,125 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | York Charles N II — COO and CFO | Option exercise (M): 2,250 · Option exercise (M): 6,625 · Option exercise (M): 6,625 · Option exercise (M): 7,875 · Sale (S): 6,065 @ $11.60 · Option exercise (M): 2,250 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-30 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 355,000 (derivative) @ $0 · Grant/award (A): 237,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Merendino Lauren — Chief Commercial Officer | Grant/award (A): 110,000 (derivative) @ $0 · Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Dubow Adam — Gen Counsel & Secretary | Grant/award (A): 105,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | VASCONCELLES MICHAEL — Head of Research and Dev. | Grant/award (A): 171,000 (derivative) @ $0 · Grant/award (A): 114,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | York Charles N II — COO and CFO | Grant/award (A): 188,000 (derivative) @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 300,000 @ $0 · Gift (G): 7,225 @ $0 · Gift (G): 7,225 @ $0 | EDGAR |
| 2025-11-18 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 3,570 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 15,894 @ $8.91 · Option exercise (M): 3,570 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-18 | 4 | Merendino Lauren — Chief Commercial Officer | Option exercise (M): 3,162 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 3,726 @ $8.91 · Option exercise (M): 3,162 (derivative) @ $0 · Option exercise (M): 3,687 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-18 | 4 | Dubow Adam — Gen Counsel & Secretary | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,319 @ $8.91 · Option exercise (M): 2,963 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-18 | 4 | York Charles N II — COO and CFO | Option exercise (M): 1,375 · Option exercise (M): 2,250 · Option exercise (M): 6,625 · Option exercise (M): 6,625 · Sale (S): 4,062 @ $8.91 · Option exercise (M): 1,375 (derivative) @ $0 · +3 more | EDGAR |
| 2025-11-07 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Disposition to issuer (D): 1,463,134 (derivative) @ $0 · Grant/award (A): 1,463,134 (derivative) @ $0 · Disposition to issuer (D): 397,000 (derivative) @ $0 · Grant/award (A): 397,000 (derivative) @ $0 · Disposition to issuer (D): 244,000 (derivative) @ $0 · Grant/award (A): 244,000 (derivative) @ $0 · +4 more | EDGAR |
| 2025-11-07 | 4 | Merendino Lauren — Chief Commercial Officer | Disposition to issuer (D): 330,200 (derivative) @ $0 · Grant/award (A): 330,200 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Josey John A. — Director | Disposition to issuer (D): 63,000 (derivative) @ $0 · Grant/award (A): 63,000 (derivative) @ $0 · Disposition to issuer (D): 1,181 (derivative) @ $0 · Grant/award (A): 1,181 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 more | EDGAR |
| 2025-11-07 | 4 | Dubow Adam — Gen Counsel & Secretary | Grant/award (A): 309,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-07 | 4 | Grossman William — Director | Disposition to issuer (D): 66,660 (derivative) @ $0 · Grant/award (A): 66,660 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Dable Habib J — Director | Disposition to issuer (D): 66,660 (derivative) @ $0 · Grant/award (A): 66,660 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | York Charles N II — COO and CFO | Disposition to issuer (D): 497,667 (derivative) @ $0 · Grant/award (A): 497,667 (derivative) @ $0 · Disposition to issuer (D): 151,000 (derivative) @ $0 · Grant/award (A): 151,000 (derivative) @ $0 · Disposition to issuer (D): 116,000 (derivative) @ $0 · Grant/award (A): 116,000 (derivative) @ $0 · +4 more | EDGAR |
| 2025-11-07 | 4 | Nicholson Garry A — Director | Disposition to issuer (D): 33,900 (derivative) @ $0 · Grant/award (A): 33,900 (derivative) @ $0 · Disposition to issuer (D): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | Holles Natalie C. — Director | Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 40,300 (derivative) @ $0 · Grant/award (A): 40,300 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 more | EDGAR |
| 2025-11-07 | 4 | Ramasastry Saira — Director | Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 47,581 (derivative) @ $0 · Grant/award (A): 47,581 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 more | EDGAR |
| 2025-11-07 | 4 | Garland J. Scott — Director | Disposition to issuer (D): 48,072 (derivative) @ $0 · Grant/award (A): 48,072 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · Disposition to issuer (D): 37,500 (derivative) @ $0 · Grant/award (A): 37,500 (derivative) @ $0 · +2 more | EDGAR |
| 2025-08-19 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Option exercise (M): 3,562 · Option exercise (M): 4,750 · Option exercise (M): 11,687 · Option exercise (M): 11,687 · Sale (S): 16,058 @ $6.77 · Option exercise (M): 3,562 (derivative) @ $0 · +3 more | EDGAR |
| 2025-08-19 | 4 | Merendino Lauren — Chief Commercial Officer | Option exercise (M): 3,162 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 3,766 @ $6.77 · Option exercise (M): 3,162 (derivative) @ $0 · Option exercise (M): 3,687 (derivative) @ $0 · +1 more | EDGAR |
| 2025-08-19 | 4 | Dubow Adam — Gen Counsel & Secretary | Option exercise (M): 2,963 · Option exercise (M): 1,750 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 4,365 @ $6.77 · Option exercise (M): 2,963 (derivative) @ $0 · +3 more | EDGAR |
| 2025-08-19 | 4 | York Charles N II — COO and CFO | Option exercise (M): 1,375 · Option exercise (M): 2,250 · Option exercise (M): 6,625 · Option exercise (M): 6,625 · Sale (S): 4,106 @ $6.77 · Option exercise (M): 1,375 (derivative) @ $0 · +3 more | EDGAR |
| 2025-07-14 | 4 | Bender Jeremy — CHIEF EXECUTIVE OFFICER, Director | Gift (G): 148,312 @ $0 · Gift (G): 148,312 @ $0 · Gift (G): 74,328 @ $0 · Gift (G): 74,328 @ $0 · Gift (G): 199,202 @ $0 · Gift (G): 199,202 @ $0 · +2 more | EDGAR |
| 2025-06-18 | 4 | VASCONCELLES MICHAEL — Head of Research and Dev. | Grant/award (A): 346,000 (derivative) @ $0 · Grant/award (A): 226,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Josey John A. — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Grossman William — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Dable Habib J — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Nicholson Garry A — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | Holles Natalie C. — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Day One Biopharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-04-23 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-24 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DAWN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →